Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling
- PMID: 9312188
- PMCID: PMC508373
- DOI: 10.1172/JCI119715
Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling
Abstract
TNF-alpha has been shown to be an important mediator of insulin resistance linked to obesity. This cytokine induces insulin resistance, at least in part, through inhibition of the tyrosine kinase activity of the insulin receptor. Recently, a new class of compounds, the antidiabetic thiazolidinediones (TZDs), has been shown to improve insulin resistance in obesity and non-insulin-dependent diabetes mellitus in both rodents and man. Here we show that TZDs have powerful effects on the ability of TNF-alpha to alter the most proximal steps of insulin signaling, including tyrosine phosphorylation of the insulin receptor and its major substrate, IRS-1, and activation of PI3-kinase. Troglitazone or pioglitazone essentially eliminate the reduction in tyrosine phosphorylation of IR and IRS-1 caused by TNF-alpha in fat cells, even at relatively high doses (25 ng/ml). That this effect of TZDs operates through activation of the nuclear receptor PPARgamma/ RXR complex is shown by the fact that similar effects are observed with other PPARgamma/RXR ligands such as 15 deoxy Delta12,14PGJ2 and LG268. The TZDs do not inhibit all TNF-alpha signaling in that the transcription factor NF-kB is still induced well. These data indicate that TZDs can specifically block certain actions of TNF-alpha related to insulin resistance, suggesting that this block may contribute to their antidiabetic actions.
Similar articles
-
Pioglitazone ameliorates tumor necrosis factor-alpha-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator--activated receptor-gamma.Diabetes. 2001 May;50(5):1083-92. doi: 10.2337/diabetes.50.5.1083. Diabetes. 2001. PMID: 11334412
-
A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.Mol Endocrinol. 1999 Mar;13(3):410-7. doi: 10.1210/mend.13.3.0246. Mol Endocrinol. 1999. PMID: 10076998
-
A selective peroxisome proliferator-activated receptor-gamma (PPARgamma) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes.Mol Endocrinol. 2000 Sep;14(9):1425-33. doi: 10.1210/mend.14.9.0528. Mol Endocrinol. 2000. PMID: 10976920
-
[Mechanisms of thiazolidinedione derivatives for hypoglycemic and insulin sensitizing effects].Nihon Rinsho. 2000 Feb;58(2):370-5. Nihon Rinsho. 2000. PMID: 10707560 Review. Japanese.
-
Thiazolidinediones--tools for the research of metabolic syndrome X.Physiol Res. 1998;47(4):215-25. Physiol Res. 1998. PMID: 9803467 Review.
Cited by
-
Molecular determinants of the cardiometabolic phenotype.Endocr Metab Immune Disord Drug _targets. 2010 Jun;10(2):109-23. doi: 10.2174/187153010791213119. Endocr Metab Immune Disord Drug _targets. 2010. PMID: 20384572 Free PMC article. Review.
-
Agonism of Peroxisome Proliferator Receptor-Gamma may have Therapeutic Potential for Neuroinflammation and Parkinson's Disease.Curr Neuropharmacol. 2007 Mar;5(1):35-46. doi: 10.2174/157015907780077123. Curr Neuropharmacol. 2007. PMID: 18615152 Free PMC article.
-
A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response.J Clin Invest. 1999 Aug;104(4):383-9. doi: 10.1172/JCI7145. J Clin Invest. 1999. PMID: 10449430 Free PMC article.
-
Nuclear Receptors in the Pathogenesis and Management of Inflammatory Bowel Disease.Mediators Inflamm. 2019 Jan 21;2019:2624941. doi: 10.1155/2019/2624941. eCollection 2019. Mediators Inflamm. 2019. PMID: 30804707 Free PMC article. Review.
-
S6K directly phosphorylates IRS-1 on Ser-270 to promote insulin resistance in response to TNF-(alpha) signaling through IKK2.J Biol Chem. 2008 Dec 19;283(51):35375-82. doi: 10.1074/jbc.M806480200. Epub 2008 Oct 24. J Biol Chem. 2008. PMID: 18952604 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical